Reply to letter by Dr. R. Menta (Vaccine 2000; 18:1-2)

By D'Argenio P.   Arigliani R.   Selvaggi T.M.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 2925-2926

Elsevier

Access to resources Recommend Favorite

Vaccine safety policy analysis in three European countries: the case of thimerosal

By Freed G.L.   Andreae M.C.   Cowan A.E.   Katz S.L.  

Health Policy, Vol. 62, Iss. 3, 2002-12 ,pp. : 291-307

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective role of three formulations of oral cholera vaccine

By Kalambaheti T.   Chaisri U.   Srimanote P.   Pongponratn E.   Chaicumpa W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite

Letter

By  

Appetite (APPET), Vol. 30, Iss. 2, 1998-04 ,pp. : 235-235

Academic Press

Access to resources Recommend Favorite

Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose

By Duval B.   Boulianne N.   De Serres G.   De Wals P.   Masse R.   Trudeau G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3632-3634

Elsevier

Access to resources Recommend Favorite